| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
2 companies
Benaim Ely is a Chief Medical Officer at NovoCure Ltd with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $411K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2021 | NVCR Novocure Ltd | Chief Medical Officer | Sell | 2,918 | $131.53 | $383,804.54 | -8.1% | |
| Mar 4, 2021 | NVCR Novocure Ltd | Chief Medical Officer | Sale+OE | 5,363 | $146.12 | $783,662.45 | -6.7% | |
| Dec 21, 2020 | NVCR Novocure Ltd | Chief Medical Officer | Sale+OE | 2,484 | $156.71 | $389,267.64 | -4.1% | |
| Aug 3, 2020 | NVCR Novocure Ltd | Chief Medical Officer | Sell | 660 | $76.06 | $50,199.60 | -2.2% | |
| Jul 31, 2020 | NVCR Novocure Ltd | Chief Medical Officer | Sell | 341 | $76.39 | $26,048.31 | -1.1% | |
| May 12, 2020 | NVCR Novocure Ltd | Chief Medical Officer | Sell | 2,595 | $64.78 | $168,104.10 | -17.1% | |
| May 11, 2020 | NVCR Novocure Ltd | Chief Medical Officer | Sale+OE | 1,611 | $63.73 | $102,665.81 | -9.6% |